Achilles Therapeutics plc has announced the transfer of data and samples from its TRACERx Non-Small Cell Lung Cancer study and its Material Acquisition Platform (MAP) to AstraZeneca for a total ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback